Clyburn Frank 4/A
4/A · Revolution Medicines, Inc. · Filed Apr 28, 2025
Insider Transaction Report
Form 4/AAmended
Clyburn Frank
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-08-05+26,540→ 26,540 totalExercise: $42.48Exp: 2034-08-05→ Common Stock (26,540 underlying)
Footnotes (1)
- [F1]The option becomes exercisable as it vests and the shares subject to the option vest with respect to 1/36 of the shares subject thereto on each monthly anniversary of August 5, 2024, subject to the reporting person's continued employment or service relationship with the Company on each such vesting date.